Diagnosis and monitoring of hepatitis C virus infection using the cobas® HCV test for use on the cobas® 4800 system

•Accurate HCV RNA measurements is important for clinical decision-making•SVR, the endpoint of HCV therapy, is defined by undetectable HCV RNA 12 or 24 weeks after the end of therapy•The cobas® HCV Test is sensitive, precise and reproducible•The cobas HCV Test accurately quantifies HCV RNA in patients receiving IFN-free DAA regimens•Overall percentage agreement of SVR for cobas HCV test and Abbott RealTime HCV was 100%